English
Regional settings| Spread | 0.08 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 29.91 |
| Open | 29.31 |
| 1-Year Change | -40.67% |
| Day's Range | 29.31 - 30.4 |
OrthoPediatrics Corp. is a medical device company, which is designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company operates through the OrthoPediatrics Segment, which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. The Company offers a range of products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform Femur, Orthex, QuickPack and ApiFix Mid-C System, to various hospitals and medical facilities throughout the United States and various international markets.
BRIEF: For the fiscal year ended 31 December 2021, Orthopediatrics Corp revenues increased 38% to $98M. Net loss decreased 51% to $16.3M. Revenues reflect Trauma and Deformity segment increase of 38% to $65.8M, Scoliosis segment increase of 35% to $28M, U.S. segment increase of 24% to $77.8M, International segment increase from $8.1M to $20.3M. Lower net loss reflects Legal settlement expenses decrease of 98% to $150K (expense).
